Cytomegalovirus (CMV) Polyradiculomyelopathy Treatment Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research Global Cytomegalovirus (CMV) Polyradiculomyelopathy Treatment Market, By Treatment (Ganciclovir, Foscarnet, Others), Dosage (Tablet, Injection, Powder, Others), Route of Administration (Oral, Intravenous, Ophthalmic, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.